SPONSOR

University Hospital, Strasbourg, France

Total Trials

Recruiting

Phases

Phase 2, Phase 4, Phase 3

Conditions studied: Hypertriglyceridemia Acute Medical Problem Gastrointestinal Bleeding Systemic Sclerosis Inflammatory Myopathies Ovarian Cancer Organ Donation Face Facial Involvement Rehabilitation

University Hospital, Strasbourg, France is a clinical research sponsor with 25 registered studies on ClinicalTrials.gov, of which 25 are actively recruiting participants. Research covers conditions including Hypertriglyceridemia, Acute Medical Problem, Gastrointestinal Bleeding, Systemic Sclerosis.

The trial portfolio spans Phase 2, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Strasbourg, France

How many clinical trials has University Hospital, Strasbourg, France sponsored?

ClinicalMetric currently tracks 25 clinical trials sponsored by University Hospital, Strasbourg, France, of which 25 are actively recruiting participants. These trials cover conditions including Hypertriglyceridemia, Acute Medical Problem, Gastrointestinal Bleeding. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Hospital, Strasbourg, France research focus on?

University Hospital, Strasbourg, France clinical trials span Hypertriglyceridemia, Acute Medical Problem, Gastrointestinal Bleeding, Systemic Sclerosis, Inflammatory Myopathies, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Hospital, Strasbourg, France clinical trial?

To participate in a University Hospital, Strasbourg, France trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Strasbourg, France trials with current recruitment status updated daily.

University Hospital, Strasbourg, France

Frequently Asked Questions — University Hospital, Strasbourg, France

Clinical Trials by University Hospital, Strasbourg, France

Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma

Outcomes of Patients Over 75 Years of Age Who Consulted the Emergency Department for a Medical Problem

Management of Gastrointestinal Bleeding Under Direct Oral Anticoagulants

Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies

Transcriptional Map of Ovarian Cancer at the Single Cell Level

Survey of Our Future Healthcare Professionals on Their Training, Knowledge, and Experience Regarding Organ Donation

Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Platelet Serotonin Deficiencies: the Strasbourg Experience

Orodental Manifestations of Rare Diseases

Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Sleep Disorders and Their Impact on Patients With Ménière's Disease

Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders

Study of Platelet Population Changes Under Circulatory Support With ECMO

Aortic Laryngeal Rehabilitation Graft

Periodontal Microbiota in Systemic Sclerosis

Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)

Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs

Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB): Proof of Concept

Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit

Chronic Kidney Disease - REAL Life Study in Alsace

Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients